Habana, Cuba

Eduardo Suarez Peztana


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eduardo Suarez Peztana

Introduction

Eduardo Suarez Peztana is a notable inventor based in Habana, Cuba. He has made significant contributions to the field of immunology, particularly through his innovative work on vaccine compositions. His research focuses on the use of epidermal growth factor (EGF) in combating EGF-dependent tumors and diseases.

Latest Patents

Eduardo holds a patent for a vaccine composition comprising autologous epidermal growth factor. This invention provides novel uses of EGF and vaccine compositions that utilize EGF as an active immunization agent. The patent emphasizes the use of autologous EGF, or its fragments and derivatives, to target the proliferation of EGF-dependent tumors. The vaccine compositions are designed to be coupled with carrier proteins, such as tetanus toxoid or cholera toxin B chain, and typically include an adjuvant like aluminum hydroxide. He has 1 patent to his name.

Career Highlights

Eduardo is affiliated with the Centro de Inmunología Molecular, where he continues to advance his research in immunology. His work has the potential to significantly impact the treatment of various EGF-dependent diseases, showcasing his dedication to medical innovation.

Collaborations

Eduardo has collaborated with notable colleagues, including Augustin Bienvenido Davila and Gisela Gonzalez Marinello. Their combined expertise contributes to the advancement of research in the field of immunology.

Conclusion

Eduardo Suarez Peztana's innovative work in vaccine development highlights the importance of research in combating serious health issues. His contributions to the field of immunology are commendable and pave the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…